Van Way C W, Faraci R P, Cleveland H C, Foster J F, Scott H W
Ann Surg. 1976 Jul;184(1):26-30. doi: 10.1097/00000658-197607000-00004.
A case of ruptured pheochromocytoma is presented, the pathophysiology discussed, and the literature reviewed. Evidence is presented that the use of alpha-adrenergic blockade in general, and phentolamine in particular, may predispose to this complication. Twelve cases of massive hemorrhagic necrosis with or without rupture were found in the literature, including the present case. Six had no operation; one survived. Six had immediate operation; 4 survived. An additional case of hemorrhage into a small pheochromocytoma following phentolamine is presented. This tumor was neither ruptured nor massively necrotic, but the case supports the hypothesis that alpha-adrenergic blockade may cause hemorrhage within the pheochromocytoma.
本文报告了一例嗜铬细胞瘤破裂的病例,讨论了其病理生理学,并回顾了相关文献。有证据表明,一般使用α-肾上腺素能阻滞剂,尤其是酚妥拉明,可能会引发这种并发症。文献中发现了12例伴有或不伴有破裂的大量出血性坏死病例,包括本病例。6例未进行手术,1例存活。6例立即进行了手术,4例存活。本文还报告了一例在使用酚妥拉明后小嗜铬细胞瘤出血的病例。该肿瘤既未破裂也无大量坏死,但该病例支持α-肾上腺素能阻滞剂可能导致嗜铬细胞瘤内出血的假说。